Stocks and Investing Stocks and Investing
Wed, April 15, 2020

Matthew Gillmor Maintained (TDOC) at Hold with Increased Target to $135 on, Apr 15th, 2020


Published on 2024-10-27 03:01:48 - WOPRAI, Matthew Gillmor
  Print publication without navigation


Matthew Gillmor of Baird, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Increased Target from $130 to $135 on, Apr 15th, 2020.

Matthew has made no other calls on TDOC in the last 4 months.



There are 9 other peers that have a rating on TDOC. Out of the 9 peers that are also analyzing TDOC, 8 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jailendra Singh of "Credit Suisse" Maintained at Hold with Increased Target to $152 on, Monday, April 6th, 2020
  • Ravi Misra of "Berenberg" Downgraded from Strong Buy to Hold on, Tuesday, March 31st, 2020
  • Sandy Draper of "SunTrust Robinson Humphrey" Maintained at Hold with Increased Target to $118 on, Thursday, March 26th, 2020
  • Allen Lutz of "B of A Securities" Reiterated at Hold with Increased Target to $140 on, Thursday, February 27th, 2020
  • David Grossman of "Stifel" Maintained at Hold with Increased Target to $110 on, Thursday, February 27th, 2020
  • Kevin Caliendo of "UBS" Maintained at Hold with Increased Target to $119 on, Thursday, February 27th, 2020
  • Jamie Stockton of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $105 on, Wednesday, February 12th, 2020
  • Steve Valiquette of "Barclays" Maintained at Hold with Increased Target to $95 on, Tuesday, January 14th, 2020


This is the rating of the analyst that currently disagrees with Matthew


  • Sean Dodge of "RBC Capital" Maintained at Buy with Increased Target to $110 on, Tuesday, January 21st, 2020
Contributing Sources